IVVD Invivyd Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: IVVD

Price (delayed)

$0.6114

Market cap

$180.12M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.31

Enterprise value

$4.6M

?
Relative Growth: Rel. Growth: 44
Relative Strength: Rel. Strength: 4
Relative Valuation: Rel. Valuation: 15
Relative Profitability: Rel. Profitability: 34

Adagio (Nasdaq: ADGI) is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company’s portfolio of antibodies has ...

Highlights
The gross profit has soared by 52% YoY and by 4.5% from the previous quarter
The revenue has soared by 52% YoY and by 4.6% from the previous quarter
IVVD's EPS has surged by 74% year-on-year but it is down by 3.3% since the previous quarter
The net income has contracted by 48% from the previous quarter but it has grown by 46% YoY
Invivyd's equity has decreased by 16% from the previous quarter
The quick ratio has contracted by 12% from the previous quarter
Sector: Healthcare
Industry: Biotechnology
Website: http://adagiotx.com
Peers: OLMA OMER VIVS ORIC

Key stats

What are the main financial stats of IVVD

IVVD stock price

How has the Invivyd stock price performed over time
Intraday
0.36%
1 week
-17.66%
1 month
-34.53%
1 year
-24.52%
YTD
-75.25%
QTD
-29.92%

Financial performance

How have Invivyd's revenue and profit performed over time
Revenue
$55.87M
Gross profit
$51.92M
Operating income
-$81.77M
Net income
-$77.6M
Gross margin
92.9%
Net margin
-138.9%
Invivyd's net margin has surged by 64% YoY but it has decreased by 41% QoQ
IVVD's operating margin has surged by 64% year-on-year but it is down by 41% since the previous quarter
The gross profit has soared by 52% YoY and by 4.5% from the previous quarter
The revenue has soared by 52% YoY and by 4.6% from the previous quarter

Price vs fundamentals

How does IVVD's price correlate with its fundamentals

Growth

What is Invivyd's growth rate over time

Valuation

What is Invivyd stock price valuation
P/E
N/A
P/B
0.85
P/S
3.39
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.08
IVVD's EPS has surged by 74% year-on-year but it is down by 3.3% since the previous quarter
The price to book (P/B) is 55% lower than the last 4 quarters average of 1.9 and 47% lower than the 5-year quarterly average of 1.6
Invivyd's equity has decreased by 16% from the previous quarter
The revenue has soared by 52% YoY and by 4.6% from the previous quarter
IVVD's price to sales (P/S) is 35% lower than its last 4 quarters average of 5.2

Efficiency

How efficient is Invivyd business performance
IVVD's return on equity has surged by 68% year-on-year but it is down by 10% since the previous quarter
IVVD's return on sales has surged by 64% year-on-year but it is down by 41% since the previous quarter
The company's return on assets has surged by 58% YoY but it fell by 21% QoQ
The ROIC has grown by 4.3% from the previous quarter

Dividends

What is IVVD's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for IVVD.

Financial health

How did Invivyd financials performed over time
Invivyd's total assets has soared by 133% YoY but it has decreased by 13% from the previous quarter
IVVD's total liabilities is down by 22% year-on-year but it is up by 9% since the previous quarter
Invivyd's debt is 96% lower than its equity
Invivyd's debt to equity has surged by 100% YoY
Invivyd's equity has decreased by 16% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.